SEC reporting owner
| Reporting owner CIK | 0001794284 |
|---|---|
| Issuers | 4 |
| Qualifying disclosures | 6 |
| Public purchases | 1 |
| Recent-window purchases | 0 |
| Recent-window sales | 3 |
| Last public filing | 2026-06-17 |
| Coverage | verified |
| Directory rank | 2,728 |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-06-16 | 2026-06-16 | DRMA | S | 11 | Not reported |
| 2026-01-06 | 2026-01-02 | DRMA | A | 2,500 | Not reported |
| 2026-01-05 | 2026-01-02 | SPRY | A | 240,000 | Not reported |
| 2025-08-22 | 2025-08-21 | SPRY | S | 12,500 | Not reported |
| 2025-05-22 | 2025-05-20 | SPRY | S | 50,000 | Not reported |
| 2025-01-14 | 2025-01-13 | DRMA | A | 5,000 | Not reported |
| 2025-01-03 | 2025-01-02 | SPRY | A | 176,700 | Not reported |
| 2024-12-10 | 2024-12-06 | NKGN | A | 500,000 | Not reported |
| 2024-12-10 | 2024-12-06 | NKGN | A | 300,000 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.